Gilead asks FDA again to approve twice-a-year HIV-fighting drug
June 27, 2022 at 19:37 PM EDT
The drug, called lenacapavir, was rejected by the FDA in February because of issues with the vials holding the injectable drug.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
